Regulation of cell death and epileptogenesis by the mammalian target of rapamycin (mTOR): A double-edged sword?

Cell Cycle

Volumn 9, Issue 12, 2010, Pages 2281-2285

  Zeng, Ling Hui ^a   McDaniel, Sharon ^b   Rensing, Nicholas R ^b   Wong, Michael ^b  

^a ZHEJIANG UNIVERSITY CITY COLLEGE   (China)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Epilepsy; Kainate; Rat; Seizure

Indexed keywords

ADENYLATE KINASE; GLUTAMATE RECEPTOR AGONIST; HAMARTIN; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P27; TUBERIN;

APOPTOSIS; CATABOLISM; CELL CYCLE PROGRESSION; CELL DEATH; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; CELL SIZE; EPILEPSY; EPILEPTIC STATE; EPILEPTOGENESIS; GLIA; METABOLIC STRESS; NERVE FIBER; NERVOUS SYSTEM DEVELOPMENT; PROTEIN SYNTHESIS; REVIEW; SEIZURE; SIGNAL TRANSDUCTION; TRAUMATIC BRAIN INJURY; TUBEROUS SCLEROSIS;

MAMMALIA; RATTUS; RODENTIA;

EID: 77954146395     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.12.11866     Document Type: Review

References (32)

1. Temkin NR. Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia 2001; 42:515-24.
2. Dichter MA. Models of epileptogenesis in adult animals available for antiepileptogenesis drug screening. Epilepsy Res 2006; 68:31-5.
3. Loscher W, Schmidt D. New horizons in the development of antiepileptic drugs: innovative strategies. Epilepsy Res 2006; 69:183-272.
4. Stefan H, Lopes da Silva FH, Loscher W, Schmidt D, Perucca E, Brodie MJ, et al. Epileptogenesis and rational therapeutic strategies. Acta Neurol Scand 2006; 113:139-55.
5. Wong M. Mammalian target of rapamycin (mTOR) inhibition as potential antiepileptogenic therapy: from tuberous sclerosis to common acquired epilepsies. Epilepsia 2010; 51:27-36.
6. Sandsmark DK, Pelletier C, Weber JD, Gutmann DH. Mammalian target of rapamycin: master regulator of cell growth in the nervous system. Histol Histopathol 2007; 22:895-903. (Pubitemid 47034156)
7. Sarbassov DD, Ali SM, Sabatini DM. Growing roles for the mTOR pathway. Cur Opin Cell Biol 2005; 17:596-603.
8. Tsang CK, Qi H, Liu LF, Zheng XFS. Targeting mammalian target of rapamycin (mTOR) for health and diseases. Drug Disc Today 2007; 12:112-24.
9. Huang J, Manning BD. The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem J 2008; 412:179-90.
10. Inoki K, Li Y, Zhu T, Wu J, Guan KL. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signaling. Nat Cell Biol 2002; 4:648-57.
11. Manning BD, Tee Ar, Loqsdon MN, Blenis J, Cantley LC. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol Cell 2002; 10:151-62.
12. Bolster DR, Crozier SJ, Kimball SR, Jefferson LS. AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through downregulated mammalian target of rapamycin (mTOR) signaling. J Biol Chem 2002; 277:23977-80.
13. Kimura N, Tokunaga C, Dalal S, Richardson C, Yoshino K, Hara K, et al. A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signaling pathway. Genes Cell 2003; 8:65-79.
14. Chung J, Kuo CJ, Crabtree GR, Blenis J. Rapamycin-FKBP specifically blocks grown-dependent activation of and signaling by the 70 kD S6 protein kinases. Cell 1992; 69:1227-36.
15. Burnett PE, Barrow RK, Cohen NA, Snyder SH, Sabatini DM. RAFT1 phosphorylation of the translational regulators p79 S6 kinase and 4E-BP1. Proc Natl Acad Sci USA 1998; 95:1432-7.
16. Fingar DC, Salarma S, Tsou C, Harlow E, Blenis J. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev 2002; 16:1472-87.
17. Kip1 by rapamycin results in G1 arrest in exponentially growing T-cell lines. Blood 1998; 91:561-9.
18. Soucek T, Yeung RS, Hengstschlager M. Inactivation of the cyclin-dependent kinase inhibitor p27-Kip1 upon loss of the tuberous sclerosis complex gene-2. Proc Natl Acad Sci USA 1998; 95:15653-8.
19. KIP1. Lab Invest 2004; 84:588-96.
20. Castedo M, Ferri KF, Kroemer G. Mammalian target of rapamycin (mTOR): Pro- and anti-apoptotic. Cell Death Differ 2002; 9:99-100. (Pubitemid 34144768)
21. Asnaghi L, Bruno P, Priulla M, Nicolin A. mTOR: a protein kinase switching between life and death. Pharmacol Res 2004; 50:545-9.
22. Meikle L, Pollizzi K, Egnor A, Kramvis I, Lane H, Sahin M, Kwiatkowski DJ. Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function. J Neurosci 2008; 28:5422-32.
23. Zeng LH, Xu L, Gutmann DH, Wong M. Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol 2008; 63:444-53.
24. Kwon CH, Zhu X, Zhang J, Baker SJ. mTOR is required for hypertrophy of Pten-deficient neuronal soma in vivo. Proc Natl Acad Sci USA 2003; 100:12923-8.
25. Ljungberg MC, Sunnen CN, Lugo JN, Anderson AE, D'Arcangelo G. Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia. Dis Model Mech 2009; 2:389-98.
26. Zhou J, Blundell J, Ogawa S, Kwon CH, Zhang W, Sinton C, et al. Pharmacological inhibition of mTORC1 suppresses anatomical, cellular and behavioral abnormalities in neural-specific Pten knock-out mice. J Neurosci 2009; 29:1773-83.
27. Chen S, Atkins CM, Liu CL, Alonso OF, Dietrich WD, Hu BR. Alterations in mammalian target of rapamycin signaling pathways after traumatic brain injury. J Cereb Blood Flow Metab 2007; 27:939-49.
28. Erlich S, Alexandrovich A, Shohami E, Pinkas-Kramarski R. Rapamycin is a neuroprotective treatment for traumatic brain injury. Neurobiol Dis 2007; 26:86-93. (Pubitemid 46436489)
29. Buckmaster PS, Ingram EA, Wen X. Inhibition of the mammalian target of rapamycin signaling pathway suppresses dentate granule cell axon sprouting in a rodent model of temporal lobe epilepsy. J Neurosci 2009; 29:8259-69.
30. Zeng LH, Rensing NR, Wong M. The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy. J Neurosci 2009; 29:6964-72.
31. Sutton G, Chandler LJ. Activity-dependent NMDA receptor-mediated activation of protein kinase B/Akt in cortical neuronal cultures. J Neurochem 2002; 82:1097-105.
32. Zhu D, Lipsky RH, Marini AM. Coactivation of the phosphatidylinositol-3- kinase/Akt signaling pathway by N-methyl-D-aspartate and TrkB receptors in cerebellar granule cell neurons. Amino Acids 2002; 23:11-7.